ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $147,000 | +6.5% | 100,514 | +3.2% | 0.00% | – |
| Q4 2016 | $138,000 | +294.3% | 97,419 | +382.3% | 0.00% | – |
| Q3 2016 | $35,000 | -50.7% | 20,200 | -46.1% | 0.00% | – |
| Q4 2015 | $71,000 | -61.2% | 37,486 | -60.8% | 0.00% | – |
| Q3 2015 | $183,000 | -83.3% | 95,549 | -59.4% | 0.00% | -100.0% |
| Q2 2015 | $1,093,000 | -77.8% | 235,467 | -79.1% | 0.00% | -75.0% |
| Q1 2015 | $4,932,000 | +20.1% | 1,128,592 | -4.7% | 0.01% | +60.0% |
| Q4 2014 | $4,108,000 | +382.7% | 1,184,082 | +483.0% | 0.01% | +400.0% |
| Q3 2014 | $851,000 | -71.1% | 203,096 | -59.6% | 0.00% | -75.0% |
| Q2 2014 | $2,947,000 | -33.6% | 502,909 | -28.6% | 0.00% | -33.3% |
| Q1 2014 | $4,440,000 | +16.1% | 704,845 | +7.9% | 0.01% | +20.0% |
| Q4 2013 | $3,823,000 | – | 653,435 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |